How does IDEX (IEX) make money?

IDEX (IEX) generates revenue primarily from Health And Science Technologies, which accounted for 43.9% of total revenue in TTM through Q1 2026. The company reported $3.53B in revenue and converted 14.4% of it into net profit, equivalent to roughly $507.70M in net income — what's left after the cost of revenue, operating expenses, interest, and income taxes.

What is the gross profit margin of IDEX (IEX)?

IDEX (IEX) reported a gross profit margin of 44.4% in TTM through Q1 2026, equivalent to $1.57B in gross profit on $3.53B in revenue. Gross margin measures how much of each dollar of revenue remains after the direct cost of producing or delivering the product — a higher figure typically signals pricing power, scale, or a less capital-intensive business model.

What is the operating profit margin of IDEX (IEX)?

IDEX (IEX) reported an operating profit margin of 20.8% in TTM through Q1 2026, equivalent to $734.40M in operating income. Operating margin captures profitability after research & development, sales & marketing, and general & administrative expenses — but before interest, taxes, and one-off items — and is the cleanest single read on the underlying business's efficiency.

What is the net profit margin of IDEX (IEX)?

IDEX (IEX) reported a net profit margin of 14.4% in TTM through Q1 2026, equivalent to $507.70M in net income. Net margin is the bottom-line share of revenue that survives every expense — operating costs, interest, and income taxes — and is the figure that flows directly into earnings per share.

Is IDEX (IEX) profitable?

Yes. IDEX (IEX) reported $507.70M in net income for TTM through Q1 2026, with a net profit margin of 14.4%. The company earned more from its operations than it paid out in costs, interest, and income taxes, leaving positive earnings on the bottom line.

How much does IDEX (IEX) spend on capital expenditures?

IDEX (IEX) spent $67.00M on capital expenditures (CapEx) during TTM through Q1 2026, roughly 1.9% of total revenue. CapEx represents long-lived investment in property, equipment, data centres, and other physical infrastructure, and is subtracted from operating cash flow to arrive at free cash flow.

How much free cash flow does IDEX (IEX) generate?

IDEX (IEX) generated $611.40M in free cash flow during TTM through Q1 2026, a free-cash-flow margin of 17.3%. Free cash flow is the cash left after capital expenditures and represents the discretionary pool the company can use to pay dividends, repurchase shares, repay debt, or fund acquisitions without raising external capital.

What is the effective tax rate of IDEX (IEX)?

IDEX (IEX) had an effective tax rate of 23.8% in TTM through Q1 2026. The effective rate is the actual share of pre-tax income paid as income taxes and can differ materially from the statutory rate due to foreign earnings mix, tax credits (such as R&D), share-based compensation deductions, and one-off discrete items.

What are the main business segments of IDEX (IEX)?

IDEX (IEX) reports revenue across 3 reportable product segments, led by Health And Science Technologies at 43.9% of total revenue in TTM through Q1 2026. See the revenue-by-segment table on this page for the full breakdown and how each segment feeds into the income-statement waterfall above.

Where does IDEX (IEX) generate most of its revenue?

UNITED STATES is the largest geographic market for IDEX (IEX), accounting for 46.1% of revenue in the most recent annual filing. The complete regional split — including international markets and any Rest-of-World rollup — is shown in the revenue-by-geography table on this page.

How IDEX Makes Money: 2026 Visual Revenue Map

IDEX (IEX) Income Statement Flow — TTM through Q1 2026

Calculated from the four most recent reported quarters, ending March 31, 2026 (reported April 29, 2026).

IDEX (IEX) Revenue by Product Segment — TTM through Q1 2026

Aggregated from the four quarterly disclosures behind this TTM. Minor differences vs the company's annual filing can occur if reported segments changed mid-year.

Revenue contribution by product segment for IDEX (IEX) in TTM through Q1 2026.
Segment	Revenue (USD)	% of total
Health And Science Technologies	$1.55B	43.9%
Fluid And Metering Technologies	$1.23B	34.9%
Fire And Safety Diversified Products	$747.78M	21.2%
Total	$3.53B	100%

Health And Science Technologies$1.55B
Fluid And Metering Technologies$1.23B
Fire And Safety Diversified Products$747.78M
Total$3.53B

IDEX (IEX) Revenue by Geography — TTM through Q1 2026

Aggregated from the four quarterly disclosures behind this TTM. Minor differences vs the company's annual filing can occur if reported regions changed mid-year.

Revenue contribution by geographic region for IDEX (IEX), TTM through Q1 2026
Region	Revenue (USD)	% of total
UNITED STATES	$1.34B	46.1%
Europe	$878.50M	30.2%
Asia	$562.00M	19.3%
North America, Excluding United States	$129.40M	4.4%
Total	$2.91B	100%

UNITED STATES
Europe
Asia
North America, Excluding United States
Total

Revenue Breakdown — TTM through Q1 2026

In TTM through Q1 2026, IDEX (IEX) reports revenue across 3 operating segments; the largest segment was Health And Science Technologies at 43.9%, followed by Fluid And Metering Technologies (34.9%) and Fire And Safety Diversified Products (21.2%). Separately, by end-market geography, UNITED STATES accounted for 46.1% of revenue, followed by Europe (30.2%) and Asia (19.3%).

Frequently asked questions

Data & methodology

IDEX (IEX) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation